Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Small Molecule Innovator API CDMO Market Investment Opportunities and ForecastThe global Small Molecule Innovator API CDMO market was valued at USD 26.7 billion in 2025 and is projected to grow from USD 28.1 billion in 2026 to USD 43.7 billion by 2033, registering a CAGR of 6.6% from 2026 to 2033. Asia Pacific accounted for the largest 41.9% revenue share in 2025, supported by expanding pharmaceutical manufacturing capabilities, cost-efficient production...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Sterile Injectables CDMO Market Future Demand AnalysisThe global Sterile Injectables CDMO Market was valued at USD 37.8 billion in 2025 and is projected to grow from USD 41.6 billion in 2026 to USD 87.3 billion by 2033, expanding at a CAGR of 11.2% from 2026 to 2033. North America accounted for the largest revenue share of 33.7% in 2025, supported by the presence of leading pharmaceutical manufacturers, strong biologics pipelines, and...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Antibody Recombinant Protein CDMO Market – Supporting Biopharmaceutical ManufacturingThe Antibody Recombinant Protein CDMO Market covers contract development and manufacturing organizations that provide specialized services for antibody and recombinant protein production. These organizations support biopharmaceutical companies throughout process development, scale-up, and manufacturing. Current Market Landscape Services may include cell-line development, process optimization,...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотр
-
Antibody Recombinant Protein CDMO Market – Supporting Biopharmaceutical ManufacturingThe Antibody Recombinant Protein CDMO Market covers contract development and manufacturing organizations that provide specialized services for antibody and recombinant protein production. These organizations support biopharmaceutical companies throughout process development, scale-up, and manufacturing. Current Market Landscape Services may include cell-line development, process optimization,...0 Комментарии 0 Поделились 16 Просмотры 0 предпросмотр
-
Botulinum Toxin CDMO Market Growth Driven by Outsourcing TrendsHow CDMOs Are Accelerating Innovation in the Botulinum Toxin Industry Introduction to the Botulinum Toxin CDMO Market The pharmaceutical industry is increasingly relying on specialized outsourcing partners to improve manufacturing efficiency, reduce operational costs, and accelerate product commercialization. Among the segments benefiting from this trend is the Botulinum Toxin CDMO Market,...0 Комментарии 0 Поделились 559 Просмотры 0 предпросмотр
-
Global Veterinary CRO and CDMO Market Projected to Hit USD 16.28 Billion by 2034The Veterinary CRO and CDMO Market is experiencing an unprecedented structural transformation, according to a comprehensive intelligence study released by Stellar Market Research. Valued at USD 7.37 billion in 2025, the market is projected to reach USD 16.28 billion by 2034, expanding at a robust compound annual growth rate (CAGR) of 9.2% over the forecast period. This acceleration underscores...0 Комментарии 0 Поделились 41 Просмотры 0 предпросмотр
-
How the Advanced Therapy Medicinal Products CDMO Market Supports Advanced Biologic DevelopmentThe demand for Advanced Therapy Medicinal Products CDMO Market is surging, driven by rising investments in cell and gene therapies. The market is projected to grow from USD 29.97 million in 2024 to USD 134.73 million by 2035, marking a compound annual growth rate (CAGR) of 14.64%. Such significant growth reflects a broader shift towards personalized medicine and innovative therapeutic...0 Комментарии 0 Поделились 566 Просмотры 0 предпросмотр
-
How The Peptide CDMO Market Supports Advanced Therapeutic ProductionThe Peptide CDMO Market is experiencing remarkable expansion as pharmaceutical companies increasingly outsource peptide manufacturing to specialized contract development and manufacturing organizations. For comprehensive market analysis and detailed industry forecasts, explore the full report available through the link provided above. Peptide-based therapeutics have emerged as one of the most...0 Комментарии 0 Поделились 467 Просмотры 0 предпросмотр
-
Key Drivers Shaping the Cell and Gene Therapy CDMO MarketThe Cell and Gene Therapy CDMO Market is undergoing a transformative phase, projected to expand significantly in the coming years. With a staggering market size increasing from $35.89 million in 2024 to an anticipated $366.93 million by 2035, the growth trajectory reflects a compound annual growth rate (CAGR) of 23.53%. This impressive escalation underscores a broader trend in personalized...0 Комментарии 0 Поделились 722 Просмотры 0 предпросмотр
-
Small Molecule CDMO Market: Opportunities and Practical Adoption ConstraintsSmall Molecule CDMO Market: Understanding Active Pharmaceutical Ingredients and End Uses What does the small molecule cdmo market include, and why are businesses paying attention? Small molecule CDMOs provide route selection, process development, chemical synthesis, analytical testing, formulation, scale-up and commercial manufacturing for pharmaceutical sponsors. Polaris Market Research values...0 Комментарии 0 Поделились 17 Просмотры 0 предпросмотр
-
Small Molecules Innovator CDMO Market Size Expands with Growing Biopharmaceutical InvestmentsThe Small Molecules Innovator CDMO Market is on the cusp of significant transformation, with a forecasted market growth that is undeniably compelling. By 2035, the market is projected to reach an impressive size of USD 80.04 billion, reflecting a robust compound annual growth rate of 4.27%. This surge is driven largely by the escalating demand for small molecule drugs across various therapeutic...0 Комментарии 0 Поделились 502 Просмотры 0 предпросмотр
-
Pharmaceutical Contract Manufacturing Market Regional Analysis and Future OutlookThe global Pharmaceutical Contract Manufacturing Market size was valued at USD 141.7 billion in 2025 and is projected to grow from USD 155.1 billion in 2026 to USD 310.9 billion by 2033, registering a CAGR of 10.4% from 2026 to 2033. North America accounted for the largest market share of 38.44% in 2025, supported by a mature pharmaceutical ecosystem, robust R&D investments, and...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Oral Solid Dosage Contract Manufacturing Market: Growth, Trends, and OutlookThe global oral solid dosage contract manufacturing market is becoming an increasingly important part of the pharmaceutical manufacturing ecosystem as drug developers and pharmaceutical companies turn to specialized contract development and manufacturing organizations (CDMOs) for formulation development, scale-up, and commercial production. Rising outsourcing activity, growing generic drug...0 Комментарии 0 Поделились 731 Просмотры 0 предпросмотр
-
Veterinary CRO CDMO Market Growth, Revenue Analysis Industry Forecast Analysis By Fact.MRROCKVILLE, MARYLAND , Sept 21, 2026 -According to the latest market study by Fact.MR (Report Code: FACT15845MR), the global Veterinary CRO CDMO Market stood at USD 6.9 billion in the 2025 base year and is projected to expand from USD 7.5 billion in 2026 to USD 16.2 billion by 2036. [Note on Source Data Consistency: The source report lists both a 2025 base-year valuation of...0 Комментарии 0 Поделились 346 Просмотры 0 предпросмотр
-
Viral Vaccines CDMO Market Growth, Revenue, Key Factors, Major Companies, Forecast Analysis By Fact.MRViral Vaccines CDMO Market to Grow at 15.3% CAGR Driven by Rising Outsourcing of Vaccine Manufacturing and Expanding Viral Vector Development Programs Rockville, Maryland, USA – According to Fact.MR, the global viral vaccines CDMO market is projected to grow from USD 2.8 billion in 2026 to USD 11.5 billion by 2036, expanding at a CAGR of 15.3% during the forecast period....0 Комментарии 0 Поделились 670 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek